USG Logo

International experts agree that no alternative should be underestimated in the fight against COVID-19

  • The online conference on COVID-19, held on April 29 and moderated by the spanish scientist Dr. Jan Tesarik, he has brought together 10 international speakers, experts in the field.
  • The main conclusion is that, in the fight against COVID-19, no alternative should be underestimated since the evolution of the virus is not very predictable, and the solutions currently under development may not work.
  • On April 29, the "E-Meeting on COVID-19: Symptoms, Diagnosis & Treatment (E-COVID)" was held. Scientists, researchers and physicians from all over the world analyzed the latest advances in the diagnosis and treatment of COVID-19.
  • The conference, organized by United Scientific Group, lasted 6 hours and addressed diagnostic, therapeutic and epidemiological aspects of the fight against this dangerous and unpredictable virus. The spanish scientist Dr. Jan Tesarik, moderated the entire meeting and presented the keynote lecture.
  • Ten experts from 7 countries, including India, Singapore, Italy, the United States, Romania, China and Spain, tackled virtually all aspects of the fight against the virus, including some relatively unorthodox ones, such as Ayurvedic medicine, traditional Chinese medicine, homeopathy and simple, cheap and risk-free treatments, such as that with melatonin, suggested for some time by Dr. Tesarik in national and international media.
  • In the final discussion of the meeting, Dr. Tesarik, supported by a large part of the speakers, has put forward the idea that no alternative should be abandoned, however remote it may seem. In fact, the genetic sequence of the COVID-19 virus can change (mutate), and we already have first signs that this is beginning to occur. Thus it is possible that a vaccine based on the current genetic sequence of the virus may lose, partially or totally, its effectiveness.
  • Dr. Tesarik comments: "I don't want to be a catastrophic prophet, but we would have to be prepared for this eventuality. So the development of alternative treatments have three functions: first, saving lives until the moment of vaccine availability, second, replacing the vaccine in the (unlikely) case of its total failure, and third, accompanying the vaccine in the event of a partial loss of efficacy or to allow reduction of its dose in case of toxicity."